0000000000049931

AUTHOR

Karsten Keller

0000-0002-0820-9584

showing 70 related works from this author

Diabetes Mellitus and Its Impact on Patient-Profile and In-Hospital Outcomes in Peripheral Artery Disease

2021

Background: In patients with peripheral artery disease (PAD), the impact of diabetes mellitus (DM) on patient-profile and adverse in-hospital events is not well investigated. Methods: The German nationwide inpatient sample 2005–2019 was used for this analysis. Hospitalized PAD patients were stratified for DM and the influence of DM on patient-profile and adverse in-hospital events was investigated. Results: Our study comprised 2,654,871 hospitalizations (54.3% aged ≥70 years, 36.7% females) of patients with PAD in Germany 2005–2019. Among these, 864,691 (32.6%) patients had DM and 76,716 (2.9%) died during hospitalization. Diabetic PAD patients revealed an aggravated cardiovascular profile …

medicine.medical_specialtyArterial diseasebusiness.industrymedicine.medical_treatmentRGeneral MedicineDiseasemedicine.diseaseperipheral artery diseaseArticlemyocardial infarctionHospital outcomesAmputationInternal medicineDiabetes mellitusamputationdiabetes mellitusmedicinePatient profileMedicineMyocardial infarctionAdverse effectbusinessJournal of Clinical Medicine
researchProduct

In-hospital outcomes of catheter-directed thrombolysis in patients with pulmonary embolism.

2020

AbstractAimsCatheter-directed treatment of acute pulmonary embolism (PE) is technically advancing. Recent guidelines acknowledge this treatment option for patients with overt or imminent haemodynamic decompensation, particularly when systemic thrombolysis is contraindicated. We investigated patients with PE who underwent catheter-directed thrombolysis (CDT) in the German nationwide inpatient cohort.Methods and resultsData from hospitalizations with PE (International Classification of Disease code I26) between 2005 and 2016 were collected by the Federal Office of Statistics in Germany. Patients with PE who underwent CDT (OPS 8-838.60 or OPS code 8-83b.j) were compared with patients receiving…

medicine.medical_specialtyCathetersTime Factorsmedicine.medical_treatment030204 cardiovascular system & hematologyCritical Care and Intensive Care MedicineLower risk03 medical and health sciences0302 clinical medicineFibrinolytic AgentsInternal medicineMedicineHumansDecompensationThrombolytic Therapy030212 general & internal medicineProspective StudiesRetrospective Studiesbusiness.industryMortality rateGeneral MedicineOdds ratioThrombolysismedicine.diseaseHospitalsPulmonary embolismTreatment OutcomeCohortCardiology and Cardiovascular MedicinebusinessPulmonary EmbolismFibrinolytic agentEuropean heart journal. Acute cardiovascular care
researchProduct

Impact of atrial fibrillation/flutter on the in-hospital mortality of ischemic stroke patients.

2020

Stroke is the second leading cause of death worldwide. Ischemic strokes, which are caused by atrial fibrillation/flutter (AF), may be more devastating than those that occur without AF.The purpose of this study was to investigate the impact of AF on adverse events in hospitalized ischemic stroke patients and to estimate the elevated impact of AF on the occurrence of these adverse events.The nationwide German inpatient sample of the years 2005-2015 was used for this analysis. Ischemic stroke patients were identified by ICD code I63 and stratified by AF. Logistic regression models were used to investigate the impact of AF on adverse in-hospital events and adjusted for age, sex, and comorbiditi…

Malemedicine.medical_specialty030204 cardiovascular system & hematologyLogistic regressionBrain Ischemia03 medical and health sciences0302 clinical medicineRisk FactorsPhysiology (medical)Internal medicineCause of DeathGermanyCase fatality rateAtrial FibrillationmedicineHumanscardiovascular diseases030212 general & internal medicineHospital MortalityAdverse effectStrokeCause of deathAgedRetrospective StudiesAged 80 and overInpatientsAtrial fibrillation flutterbusiness.industryAtrial fibrillationMiddle Agedmedicine.diseasePrognosisSurvival RateAtrial FlutterIschemic strokeCardiologyFemaleCardiology and Cardiovascular MedicinebusinessHeart rhythm
researchProduct

D-dimer for risk stratification in haemodynamically stable patients with acute pulmonary embolism

2015

Patients with submassive pulmonary embolism (PE) have a higher short-term mortality than those with low-risk PE. Rapid identification of submassive PE is important for adequate treatment of non-massive PE. We aimed to investigate the utility of D-dimer for the prediction of submassive PE stadium in normotensive PE patients.Normotensive PE patients were classified into submassive or low-risk PE groups. In addition to the comparison of the groups, area under the curve (AUC) and D-dimer cut-off for the prediction of submassive PE stadium, multi-variate logistic regression for association between D-dimer values above this cut-off and submassive PE stadium were also calculated.The data of 129 no…

Malemedicine.medical_specialtyVentricular Dysfunction RightFibrin Fibrinogen Degradation ProductsTachycardiaInternal medicineHeart rateD-dimerHumansMedicineIn patientAgedRetrospective StudiesAged 80 and overbusiness.industryArea under the curveGeneral MedicineMiddle Agedmedicine.diseasePulmonary embolismLogistic ModelsBlood pressureHaemodynamically stableRisk stratificationCardiologyFemalePulmonary EmbolismbusinessAdvances in Medical Sciences
researchProduct

Telemedicine-Based Specialized Care Improves the Outcome of Anticoagulated Individuals with Venous Thromboembolism-Results from the thrombEVAL Study.

2020

Venous thromboembolism (VTE) is a life-threatening disease with risk of recurrence. Oral anticoagulation (OAC) with vitamin K antagonists (VKA) is effective to prevent thromboembolic recurrence. We aimed to investigate the quality of OAC of VTE patients in regular medical care (RMC) compared to a telemedicine-based coagulation service (CS). The thrombEVAL study (NCT01809015) is a prospective, multi-center study to investigate OAC treatment (recruitment: January 2011&ndash

medicine.medical_specialtyANTITHROMBOTIC THERAPYPULMONARY-EMBOLISMvenous thromboembolismlcsh:Medicine030204 cardiovascular system & hematologyRate ratioWARFARINArticle03 medical and health sciences0302 clinical medicineInterquartile rangeInternal medicinemedicineORAL ANTICOAGULATION030212 general & internal medicineAdverse effectcoagulation serviceINR CONTROLNORMALIZED RATIO CONTROLPRACTICAL MANAGEMENTbusiness.industrySTROKE PREVENTIONlcsh:RHazard ratioWarfarinAtrial fibrillationGeneral Medicinemedicine.diseaseConfidence intervalMEDICAL-CAREPulmonary embolismvitamin K antagonistsATRIAL-FIBRILLATIONe-healthbusinessoral anticoagulation therapymedicine.drugJournal of clinical medicine
researchProduct

Centre procedural volume and adverse in‐hospital outcomes in patients undergoing percutaneous transvenous edge‐to‐edge mitral valve repair usingMitra…

2021

AIMS The number of transcatheter mitral valve repair (TMVr) procedures has increased substantially during the last years. A better understanding of the relationship between hospital volume of transcatheter transvenous mitral valve repairs using MitraClip® and patient outcomes may provide information for future policy decisions to improve patient management. METHODS AND RESULTS We analysed patient characteristics and in-hospital outcomes for all TMVr procedures using MitraClip® performed in Germany from 2011 to 2017. Hospitals were stratified according to centre volumes and patients were compared for baseline characteristics and adverse in-hospital events. Overall, 24 709 inpatients were tre…

Cardiac Catheterizationmedicine.medical_specialtyPercutaneousmedicine.medical_treatment030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineGermanyMitral valvemedicineHumansHeart FailureHeart Valve Prosthesis ImplantationMitral regurgitationMitral valve repairbusiness.industryMitraClipMitral Valve InsufficiencyOdds ratiomedicine.diseaseHospitalsConfidence intervalSurgeryPulmonary embolismTreatment Outcomemedicine.anatomical_structureHeart Valve ProsthesisMitral ValveCardiology and Cardiovascular MedicinebusinessEuropean Journal of Heart Failure
researchProduct

Blood pressure for outcome prediction and risk stratification in acute pulmonary embolism.

2015

Abstract Introduction Risk stratification of patients with acute pulmonary embolism (PE) is crucial in deciding appropriate therapy management. Blood pressure (BP) is rapidly available and a reliable parameter. We aimed to investigate BP for short-term outcome in acute PE. Materials and methods Data of 182 patients with acute PE were analyzed retrospectively. Logistic regression models were calculated to investigate associations between BP and in-hospital-death as well as myocardial necrosis. Moreover, receiver operating characteristic (ROC) curves and cutoff values for systolic and diastolic BPs predicting in-hospital death and myocardial necrosis were computed. Results A total of 182 pati…

AdultMalemedicine.medical_specialtyAdolescentDiastoleBlood PressureRisk AssessmentNecrosisYoung AdultInternal medicinemedicineHumansHospital MortalityAgedRetrospective StudiesAged 80 and overmedicine.diagnostic_testReceiver operating characteristicbusiness.industryVentilation/perfusion scanMyocardiumArea under the curveBlood Pressure DeterminationGeneral MedicineOdds ratioMiddle Agedmedicine.diseasePrognosisConfidence intervalSurgeryPulmonary embolismBlood pressureLogistic ModelsROC CurveAcute DiseaseEmergency MedicineCardiologyFemalebusinessPulmonary EmbolismThe American journal of emergency medicine
researchProduct

Venous thromboembolism in patients hospitalized for hip joint replacement surgery

2020

Venous thromboembolism (VTE) is a potentially life-threatening disease. Major transient risk factors include trauma, surgery, and immobilization. Patients undergoing hip joint replacement (HJR) are characterized by a high risk of postoperative VTE, but data on the time trends of VTE rates in this population are sparse.In an analysis of the German nationwide inpatient sample, we included all hospitalizations for elective primary HJR in Germany from 2005 to 2016. Time trends of the surgical procedure, overall death rates, and VTE rates were analysed, and predictors of VTE identified.Overall, 1,885,839 inpatients with elective primary HJR (59.1% women, 51.4% ≥70 years) were included in the ana…

Malemedicine.medical_specialtyArthroplasty Replacement HipPopulation2720 Hematology610 Medicine & healthDisease030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineRisk FactorsHip replacementGermanymedicineHumanscardiovascular diseasesHospital Mortalityeducationeducation.field_of_studybusiness.industryMortality rate10031 Clinic for AngiologyCancerPerioperativeVenous ThromboembolismHematologyequipment and suppliesmedicine.diseaseSurgeryPulmonary embolismHospitalization030220 oncology & carcinogenesisFemalebusinessVenous thromboembolism
researchProduct

Feasibility of a MPR-based 3DTEE guidance protocol for transcatheter direct mitral valve annuloplasty.

2020

Objectives Several interventional approaches have been established for the treatment of severe mitral regurgitation (MR) in patients at elevated risk for surgery. Direct annuloplasty is a relatively novel option in transcatheter mitral valve repair dedicated to reverse pathology in specific subsets of MR. With regard to echocardiographic guidance, this procedure presents with higher efforts in comparison with edge-to-edge therapy to enable safe and exact positioning of the device's anchors; evidence on optimal peri-interventional imaging is sparse. We tested a specific 3D-echo-guidance protocol implementing single-beat multiplanar reconstruction (MPR) and evaluated its feasibility. Methods …

medicine.medical_specialtyCardiac CatheterizationMitral Valve Annuloplastycomputer.internet_protocol610 Medizin030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineMitral valve annuloplasty610 Medical sciencesMedicineFluoroscopyHumansRadiology Nuclear Medicine and imagingIn patient030212 general & internal medicineECHO protocolProtocol (science)Heart Valve Prosthesis ImplantationMitral regurgitationmedicine.diagnostic_testbusiness.industryMitral Valve InsufficiencyMultiplanar reconstructionTreatment OutcomeFeasibility StudiesTranscatheter mitral valve repairRadiologyCardiology and Cardiovascular MedicinebusinesscomputerEchocardiography (Mount Kisco, N.Y.)REFERENCES
researchProduct

Sex-specific differences in mortality and the obesity paradox of patients with myocardial infarction ages70 y.

2017

Abstract Objectives Recent studies suggest an obesity survival paradox in patients with acute myocardial infarction (MI). The aim of this study was to investigate the in-hospital mortality of patients aged ≥70 y with acute MI relative to sex and obesity. Methods We selected patients ≥70 y of age with a diagnosis of acute MI based on the International Classification of Diseases (ICD) code I21 in the nationwide database of the Federal Statistical Office of Germany in 2014. We stratified the patients for sex and obesity versus nonobesity, and obesity classes I, II, and III. We compared the in-hospital mortality of these groups. Results In 2014, 122 607 patients ≥70 y of age were diagnosed with…

Malemedicine.medical_specialtyEndocrinology Diabetes and MetabolismMyocardial Infarction030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineSex FactorsInternal medicineGermanymedicineHumansIn patient030212 general & internal medicineMyocardial infarctionHospital MortalityObesityAgedNutrition and Dieteticsbusiness.industryMortality rateIncidence (epidemiology)Age FactorsRelative mortalitymedicine.diseaseObesitySex specificCardiologyFemalebusinessObesity paradoxNutrition (Burbank, Los Angeles County, Calif.)
researchProduct

Survival Benefit of Obese Patients With Pulmonary Embolism.

2018

To investigate the impact of obesity and underweight on adverse in-hospital outcomes in pulmonary embolism (PE).Patients diagnosed as having PE based on International Statistical Classification of Diseases and Related Health Problems, 10th Revision, German Modification code I26 in the German nationwide inpatient database were stratified for obesity, underweight, and normal weight/overweight (reference group) and compared regarding adverse in-hospital outcomes.From January 1, 2011, through December 31, 2014, 345,831 inpatients (53.3% females) 18 years and older were included in this analysis; 8.6% were obese and 0.5% were underweight. Obese patients were younger (67.0 vs 73.0 years), were mo…

Malemedicine.medical_specialtymedicine.medical_treatmentEmbolectomyOverweightThinnessInterquartile rangeInternal medicinemedicineHumansHospital MortalityObesitySurvival rateAgedAged 80 and overbusiness.industryMortality rateGeneral MedicineMiddle Agedmedicine.diseasePulmonary embolismSurvival RateFemalemedicine.symptomUnderweightbusinessPulmonary EmbolismBody mass indexMayo Clinic proceedings
researchProduct

Impact of atrial fibrillation on in-hospital mortality of ischemic stroke patients and identification of promoting factors of atrial thrombi – Result…

2019

Abstract Ischemic stroke is one of the leading causes of death and disability. Atrial fibrillation (AF) is a well-recognized risk factor for ischemic stroke. We aimed to investigate the impact of AF on in-hospital mortality of ischemic stroke patients and to identify parameters associated with intra-cardiac thrombogenic material. Patients were selected by screening the nationwide sample for ischemic stroke by ICD-Code (I63), stratified for AF. In this cohort, the association between in-hospital deaths and AF was investigated. In a second study, we performed a retrospective analysis of patients who underwent transesophageal echocardiography (TEE) for various reasons, assigned these to 2 grou…

Malemedicine.medical_specialty3400left atrial appendageObservational StudyComorbidity03 medical and health sciences0302 clinical medicineInternal medicineGermanyAtrial FibrillationmedicineechocardiographyHumans030212 general & internal medicineHospital MortalityRisk factorThrombusAgedRetrospective StudiesAged 80 and overbusiness.industryIncidence (epidemiology)Mortality rateAge FactorsRetrospective cohort studyAtrial fibrillationThrombosisGeneral MedicineMiddle Agedmedicine.diseaseComorbiditymortalitystroke3. Good health030220 oncology & carcinogenesisintracardiac thrombogenic materialCohortCardiologyFemalebusinessEchocardiography TransesophagealResearch ArticleMedicine
researchProduct

Right ventricular dysfunction in hemodynamically stable patients with acute pulmonary embolism

2013

Abstract Background Echocardiography for risk stratification in hemodynamically stable patients with pulmonary embolism (PE) is well-established. Right ventricular dysfunction (RVD) is associated with an elevated mortality and adverse outcome. The aim of our study was to compare RVD criteria and investigate the role of elevated systolic pulmonary artery pressure (sPAP) in the diagnosis of RVD. Methods We retrospectively analyzed the echocardiographic and laboratory data of all hemodynamically stable patients with confirmed PE (2006-2011). The data were compared with three different definitions of RVD: Definition 1: RV dilatation, abnormal motion of interventricular septum, RV hypokinesis or…

Malemedicine.medical_specialtyVentricular Dysfunction RightInternal medicinemedicine.arteryTroponin ImedicineHumansInterventricular septumAgedRetrospective StudiesAged 80 and overmedicine.diagnostic_testbiologyVentilation/perfusion scanbusiness.industryTroponin IHeartHematologyMiddle AgedRight bundle branch blockPrognosismedicine.diseaseTroponinPulmonary embolismmedicine.anatomical_structureEchocardiographyAcute DiseasePulmonary arterybiology.proteinCardiologyFemalePulmonary EmbolismbusinessElectrocardiographyThrombosis Research
researchProduct

Sex-specific differences regarding seasonal variations of incidence and mortality in patients with myocardial infarction in Germany

2019

Seasonal variation regarding the incidence and the short-term mortality of acute myocardial infarction (MI) was frequently reported, but data about sex-specific differences are sparse.We analysed the impact of seasons and temperature on incidence and in-hospital mortality of patients with acute MI in Germany between 2005 and 2015.The nationwide sample comprised 3,008,188 hospitalizations of MI patients (2005-2015). The incidence was 334.7/100,000 citizens/year. Incidence inclined from 316.3 to 341.6/100,000 citizens/year (β 0.17 [0.10 to 0.24], P  0.001), while in-hospital mortality rate decreased from 14.1% to 11.3% (β -0.29 [-0.30 to -0.28], P  0.001). Overall, 377,028 (12.5%) patients di…

MaleMyocardial Infarction030204 cardiovascular system & hematology03 medical and health sciencesSex Factors0302 clinical medicineGermanymedicineHumansIn patientHospital Mortality030212 general & internal medicineMyocardial infarctionSex DistributionAcute miAgedRetrospective Studiesbusiness.industryIncidenceMortality rateIncidence (epidemiology)Seasonalitymedicine.diseaseSex specificHospitalizationSurvival RateSummer seasonFemaleSeasonsCardiology and Cardiovascular MedicinebusinessFollow-Up StudiesForecastingDemographyInternational Journal of Cardiology
researchProduct

Association of transcatheter direct mitral annuloplasty with acute anatomic, haemodynamic, and clinical outcomes in severe mitral valve regurgitation.

2020

Abstract Aims Several approaches for transcatheter mitral valve repair for functional mitral valve regurgitation are established. Interventional direct annuloplasty is a novel trans‐venous, trans‐septal approach. While feasibility was proven recently, knowledge on its influence on cardiac dimensions, pressures, biomarkers, and clinical outcomes is sparse. Methods and results Patients consecutively treated with direct annuloplasty‐only procedures between December 2015 and April 2018 were included in this monocentric analysis. Echocardiographic measurements, biomarker levels, clinical status [New York Heart Association (NYHA) class and 6 min walk test] were assessed at baseline, at discharge,…

medicine.medical_specialtymedicine.medical_treatmentHemodynamicsIntracardiac pressureHeart failure030204 cardiovascular system & hematologyMultidisciplinary heart team03 medical and health sciences0302 clinical medicineInternal medicineOriginal Research ArticlesMedicineDiseases of the circulatory (Cardiovascular) system030212 general & internal medicineOriginal Research ArticleDiminutionMitral valve repairbiologybusiness.industrymedicine.diseaseTroponinMitral valve diseaseTranscatheter direct annuloplastyHeart failureRC666-701biology.proteinCardiologyBiomarker (medicine)Cardiology and Cardiovascular MedicinebusinessMitral valve regurgitationMitral valve repairESC heart failureReferences
researchProduct

Sex-specific differences in pulmonary embolism

2019

Abstract Introduction Sex-specific differences regarding risk factors, symptoms and prognosis have been reported for several cardiovascular diseases. For patients with pulmonary embolism (PE), sex-specific data are limited and inconsistent. We aimed to investigate sex-specific differences in PE. Materials and methods Over a 10-year period (01/2003–09/2013), patients with confirmed PE were enrolled in a prospective single-centre cohort study. Results We prospectively examined 569 PE patients (55.9% women). Men more often had cancer (20.7% vs. 13.5%, p = 0.024) and unprovoked PE (61.0% vs. 47.5%, p = 0.001) while women more frequently presented with risk factors for venous thromboembolism suc…

MaleTachycardiamedicine.medical_specialty030204 cardiovascular system & hematologyCohort Studies03 medical and health sciences0302 clinical medicineInternal medicineHumansMedicineProspective StudiesAgedSex Characteristicsbusiness.industryCancerHematologyMiddle AgedHypoxia (medical)medicine.diseaseSex specific3. Good healthPulmonary embolism030220 oncology & carcinogenesisRisk stratificationBiomarker (medicine)Femalemedicine.symptomPulmonary EmbolismbusinessCohort studyThrombosis Research
researchProduct

Right bundle branch block and SIQIII-type patterns for risk stratification in acute pulmonary embolism.

2016

Abstract Introduction Risk stratification in acute pulmonary embolism (PE) is crucial for identification of patients with poor prognosis. We aimed to investigate the ECG alterations of right bundle branch block (RBBB) and S I Q III -type patterns for risk stratification in acute PE. Materials and methods Retrospective analysis of PE patients, treated in the Internal Medicine Department, was performed. Patients with RBBB and/or S I Q III -type were compared with those without both patterns. Logistic regression models for association between these ECG alterations and respectively right ventricular dysfunction (RVD), high-risk PE status and myocardial injury were computed. Results 175 patients…

AdultMalemedicine.medical_specialtyBundle-Branch BlockComorbidityRisk AssessmentSensitivity and SpecificityElectrocardiographyInternal medicineGermanyHeart rateTroponin IMedicineHumansDiagnosis Computer-AssistedAgedBundle branch blockmedicine.diagnostic_testbiologybusiness.industryVentilation/perfusion scanIncidenceReproducibility of ResultsRight bundle branch blockMiddle Agedmedicine.diseaseTroponinPulmonary embolismCausalityAcute Diseasebiology.proteinCardiologyFemaleCardiology and Cardiovascular MedicinebusinessPulmonary EmbolismElectrocardiographyJournal of electrocardiology
researchProduct

Sex-specific and age-related seasonal variations regarding incidence and in-hospital mortality of pulmonary embolism in Germany

2020

Background Studies have reported seasonal variations regarding the incidence and the short-term mortality of pulmonary embolism (PE). The aim of this study was to identify sex-specific and age-related differences in seasonal patterns regarding hospitalisations and mortality of PE patients. Methods We analysed the impact of seasons on incidence and in-hospital mortality of male and female hospitalised PE patients in Germany (2005–2015) based on the German nationwide inpatient sample. Results The German nationwide inpatient sample comprised 885 806 hospitalisations due to PE (2005–2015). Seasonal variations of both incidence (p=0.021) and in-hospital mortality (p<0.001) were of significant ma…

Pulmonary and Respiratory MedicinePulmonary Vascular Disease7In hospital mortalitybusiness.industryIncidence (epidemiology)lcsh:Rlcsh:MedicineOriginal ArticlesSeasonalitymedicine.diseaseSex specificPulmonary embolismMale patientAge relatedFemale patientMedicinebusinessDemographyERJ Open Research
researchProduct

The risk factor age in normotensive patients with pulmonary embolism: Effectiveness of age in predicting submassive pulmonary embolism, cardiac injur…

2015

Abstract Introduction Right ventricular dysfunction (RVD), submassive pulmonary embolism (PE), elevated systolic pulmonary artery pressure (sPAP), elevated cardiac troponin I (cTnI) and old age are well-known risk factors for poor outcome in acute normotensive PE. The aim of this analysis was to calculate age cut-off values to predict submassive PE, cardiac injury, RVD and elevated sPAP in normotensive PE patients. Methods Retrospective analysis of clinical, laboratory, radiological and echocardiographic data of normotensive PE patients (2006–2011) was performed. Receiver operating characteristic (ROC) curves and Youden indexes were used to test the effectiveness of using patients' ages at …

MaleAgingmedicine.medical_specialtyCardiac troponinVentricular Dysfunction RightBlood PressureBiochemistryRisk AssessmentEndocrinologyRisk FactorsInternal medicinemedicine.arteryGermanyTroponin IGeneticsmedicineHumansPulmonary Wedge PressureRisk factorMolecular BiologyAgedRetrospective StudiesReceiver operating characteristicbusiness.industryTroponin IAge FactorsCell Biologymedicine.diseasePrognosisThrombosisRight ventricular dysfunctionPulmonary embolismROC CurveEchocardiographyPulmonary arteryAcute DiseaseCardiologyFemalebusinessPulmonary EmbolismExperimental gerontology
researchProduct

Impact of symptomatic atherosclerosis in patients with pulmonary embolism

2019

Atherosclerosis is associated with increased cardiovascular mortality. Associations between venous thromboembolism and atherosclerosis were recently reported. We aimed to investigate the impact of symptomatic atherosclerosis on adverse outcomes in patients with pulmonary embolism (PE) and to identify significant differences among patients with PE stratified by symptomatic atherosclerosis.Patients were selected by screening the nationwide inpatients sample for PE (ICD-code I26) stratified by symptomatic atherosclerosis (composite of coronary artery disease [ICD-code I25], myocardial infarction [ICD-code I21], ischemic stroke [ICD-code I63], and/or atherosclerotic arterial diseases [ICD-code …

Malemedicine.medical_specialtyDeep vein030204 cardiovascular system & hematologyThrombophlebitisCoronary artery disease03 medical and health sciences0302 clinical medicineRisk FactorsInternal medicinemedicineHumansHospital Mortality030212 general & internal medicineMyocardial infarctionThrombusAgedAged 80 and overbusiness.industryAge FactorsMiddle AgedAtherosclerosismedicine.diseaseThrombosisPulmonary embolismmedicine.anatomical_structureHeart failureCardiologyFemalePulmonary EmbolismCardiology and Cardiovascular MedicinebusinessInternational Journal of Cardiology
researchProduct

Impact of exaggerated blood pressure response in normotensive individuals on future hypertension and prognosis: Systematic review according to PRISMA…

2016

Abstract Purpose Arterial hypertension (aHT) is the leading risk factor for morbidity and mortality worldwide. Blood pressure (BP) deviation at rest is well defined and accompanies risk for cardiovascular events and cardiovascular mortality. A growing body of evidence emphasises that an exaggerated blood pressure response (EBPR) in cardiopulmonary exercise testing (CPET) could help to identify seemingly cardiovascular healthy and normotensive subjects, who have an increased risk of developing aHT and cardiovascular events in the future. Materials and methods The PubMed online database was searched for published studies reporting exercise-related BP and both the risk of aHT and cardiovascula…

medicine.medical_specialtybusiness.industryBlood PressureCardiopulmonary exercise testingGeneral MedicineGuideline030204 cardiovascular system & hematologyPrognosisNew onset03 medical and health sciences0302 clinical medicineBlood pressureIncreased riskHypertensionEmergency medicineExercise TestmedicinePhysical therapyHumans030212 general & internal medicineRisk factorbusinessCardiovascular mortalityAdvances in Medical Sciences
researchProduct

Psoriasis and Its Impact on In-Hospital Outcome in Patients Hospitalized with Acute Kidney Injury

2020

Background: Psoriasis is a chronic inflammatory disease which affects the body far beyond the skin. Whereas there is solid evidence that chronic skin inflammation in psoriasis drives cardiovascular disease, the impact on renal impairment and acute kidney injury (AKI) is still unclear. We aimed to analyze the impact of psoriasis on the in-hospital outcome of patients hospitalized with AKI. Methods: In this retrospective database study, we investigated data on characteristics, comorbidities, and in-hospital outcomes for all hospitalized patients with AKI stratified for concomitant psoriasis, which were collected by the Federal Office of Statistics in Germany between 2005 and 2016. Results: Am…

trendsmedicine.medical_specialtymedicine.medical_treatmentdermatoepidemiologylcsh:MedicineDisease030204 cardiovascular system & hematologyurologic and male genital diseasesArticle030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineAKIInternal medicinePsoriasismedicineIn patientMyocardial infarctionStrokeDialysisbusiness.industrylcsh:RAcute kidney injuryGeneral Medicinepsoriasismedicine.diseasemortalityConcomitantbusinessJournal of Clinical Medicine
researchProduct

Impact of Atrial Fibrillation on Postoperative Adverse Outcomes of Surgical Patients With Knee Endoprosthetic Surgery

2018

Atrial fibrillation/flutter (AF) is associated with increased mortality, thromboembolism, heart failure, and adverse perioperative outcomes. We aimed to investigate the impact of AF on adverse in-hospital outcomes of hospitalized patients who underwent knee endoprosthetic surgery (KES).The nationwide German inpatient sample of the years 2005-2015 was used for this analysis. Patients who underwent KES were identified based on the surgical and interventional procedural codes (surgery and procedure code [Operationen-und Prozedurenschlüssel] 5-822), and patients were further stratified by AF (International Classification of Diseases and Related Health Problems code I48). We compared patients wi…

Malemedicine.medical_specialtymedicine.medical_treatmentMyocardial Infarction030204 cardiovascular system & hematology03 medical and health sciencesPostoperative Complications0302 clinical medicineRisk FactorsCause of DeathGermanyThromboembolismAtrial FibrillationOdds RatiomedicineHumansOrthopedics and Sports MedicineHospital MortalityPostoperative Period030212 general & internal medicineMyocardial infarctionArthroplasty Replacement KneeStrokeAgedHeart FailureInpatientsbusiness.industryAtrial fibrillationPerioperativeLength of StayMiddle Agedmedicine.diseaseArthroplastyPulmonary embolismSurgeryStrokeLogistic ModelsRelative riskHeart failureFemalebusinessThe Journal of Arthroplasty
researchProduct

Disturbed Glucose Metabolism and Left Ventricular Geometry in the General Population

2021

Background: This study sought to investigate the prevalence and clinical outcome of left ventricular (LV) geometry in prediabetes and type 2 diabetes mellitus (T2DM) and the impact of glucose metabolism on the incidence of left ventricular hypertrophy (LVH). Methods: 15,010 subjects (35–74 years) of the population-based Gutenberg Health Study were categorized into euglycemia, prediabetes, and T2DM according to clinical and metabolic (HbA1c) information. Clinical outcome was assessed via structured follow-up. Results: The study comprised 12,121 individuals with euglycemia (81.6%), 1415 with prediabetes (9.5%), and 1316 with T2DM (8.9%). Prevalence of LVH increased from euglycemia (10.2%) ove…

medicine.medical_specialtyendocrine system diseasestype 2 diabetes mellitusPopulationprediabetesCarbohydrate metabolismleft ventricular concentric remodelingLeft ventricular hypertrophyArticleInternal medicineMedicineMass indexPrediabetescardiovascular diseaseseducationeducation.field_of_studybusiness.industryIncidence (epidemiology)Hazard ratioRType 2 Diabetes Mellitusnutritional and metabolic diseasesGeneral Medicinemedicine.diseaseleft ventricular hypertrophyleft ventricular geometryCardiologyMedicinebusinessJournal of Clinical Medicine
researchProduct

Psoriasis and its impact on the clinical outcome of patients with pulmonary embolism

2021

Abstract Background Venous thromboembolism (VTE) is common and associated with high morbidity and mortality. Although chronic inflammation was not categorized as a traditional risk factor for VTE, chronic inflammation might increase the risk to develop VTE events. While studies confirmed an increased cardiovascular morbidity and mortality in psoriatic patients, data regarding the influence of psoriasis on patients' cardiovascular profile and on prognosis of patients with pulmonary embolism (PE) are sparse. Purpose We aimed to investigate the impact of psoriasis on prognosis of PE patients. Methods Hospitalized PE patients were stratified for psoriasis and the impact of psoriasis on outcome …

Malemedicine.medical_specialtyYounger agebusiness.industryVenous Thromboembolismmedicine.diseasePulmonary embolismVenous thrombosisIncreased riskRisk FactorsInternal medicinePsoriasismedicineHumansPsoriasisFemaleHospital MortalityPulmonary EmbolismCardiology and Cardiovascular MedicinebusinessVenous thromboembolismAgedEuropean Heart Journal
researchProduct

Clinical impact of diabetes mellitus in patients hospitalized for myocardial infarction

2020

Abstract Background Diabetes mellitus (DM) represents a major cardiovascular risk factor for coronary artery disease and myocardial infarction (MI). Purpose We aimed to assess in-hospital events and time trends in MI patients with and without DM between 2005 and 2016 in Germany. Methods The nationwide German inpatient sample 2005–2016 was used for statistical analysis (source: Research Data Center (RDC) of the Federal Statistical Office and the Statistical Offices of the federal states, DRG Statistics 2005–2016, own calculations). Hospitalized MI patients were stratified for the presence of DM and the impact of DM on in-hospital events was investigated. Results A total of 3,307,703 patients…

medicine.medical_specialtybusiness.industryAtrial fibrillationmedicine.diseaseComorbidityObesityThrombosisPneumoniaInternal medicineDiabetes mellitusmedicineMyocardial infarctionCardiology and Cardiovascular MedicineHemostatic functionbusinessEuropean Heart Journal
researchProduct

Trends in thrombolytic treatment and outcomes of acute pulmonary embolism in Germany.

2019

Abstract Aims Pulmonary embolism (PE) is the third most common cardiovascular cause of death; systemic thrombolysis is potentially lifesaving treatment in patients presenting with haemodynamic instability. We investigated trends in the use of systemic thrombolysis and the outcome of patients with acute PE. Methods and results We analysed data on the characteristics, comorbidities, treatment, and in-hospital outcome of 885 806 PE patients in Germany between 2005 and 2015. Incidence of acute PE was 99/100 000 population/year and increased from 85/100 000 in 2005 to 109/100 000 in 2015 [β 0.32 (0.26–0.38), P &amp;lt; 0.001]. During the same period, in-hospital case fatality rates decreased fro…

Malemedicine.medical_specialtyTime Factorsmedicine.medical_treatmentPopulation030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineFibrinolytic AgentsRisk FactorsInternal medicineGermanyCase fatality ratemedicineHumansThrombolytic TherapyCardiopulmonary resuscitationHospital MortalityeducationCause of deathAgedRetrospective StudiesAged 80 and overeducation.field_of_studybusiness.industryMortality rate030229 sport sciencesThrombolysisMiddle Agedmedicine.diseasePulmonary embolismTreatment OutcomeAcute DiseaseCardiologyFemaleCardiology and Cardiovascular MedicinebusinessPulmonary EmbolismFibrinolytic agentFollow-Up StudiesEuropean heart journal
researchProduct

Syncope in the German Nationwide inpatient sample – Syncope in atrial fibrillation/flutter is related to pulmonary embolism and is accompanied by hig…

2019

Syncope is a common phenomenon in the general population. Although most of the causes are of benign origin, some comorbidities are accompanied by high mortality. We aimed to compare the in-hospital mortality of patients with syncope related to different comorbities and investigate the impact of syncope in patients with atrial fibrillation/flutter (AF).The nationwide inpatient sample of Germany of the years 2011-2014 was used for this analysis. Patients with syncope (ICD-code R55) were stratified by presence of selected comorbidities. Additionally, AF patients with and without syncope were compared. Incidence of syncope and in-hospital mortality were calculated. Syncope as a predictor of adv…

AdultMalemedicine.medical_specialtyPopulationMyocardial InfarctionComorbidity030204 cardiovascular system & hematologySyncopeYoung Adult03 medical and health sciences0302 clinical medicineRisk FactorsCause of DeathGermanyInternal medicineAtrial FibrillationInternal MedicinemedicineHumansHospital Mortality030212 general & internal medicineMyocardial infarctioneducationStrokeAgedAged 80 and overHeart Failureeducation.field_of_studybiologybusiness.industryIncidenceMortality rateIncidence (epidemiology)Syncope (genus)Atrial fibrillationPneumoniaMiddle Agedmedicine.diseasebiology.organism_classificationPulmonary embolismStrokeLogistic ModelsMultivariate AnalysisCardiologyFemalePulmonary EmbolismbusinessEuropean Journal of Internal Medicine
researchProduct

Impact of chronic obstructive pulmonary disease on the outcomes of patients with peripheral artery disease.

2019

Peripheral artery disease (PAD) and chronic obstructive pulmonary disease (COPD) are both related with high in-hospital mortality. We aimed to investigate the impact of COPD on the in-hospital outcomes in PAD.PAD patients were selected based on ICD-code I70.2 of the German nationwide database, stratified for COPD and compared regarding adverse in-hospital outcomes.Between 01/2005-12/2015, 5,611,827 inpatients (64.8% males) were diagnosed with PAD; of those, 13.6% were coded additionally with COPD. Overall, 277,894 PAD patients (5.0%) died during in-hospital course. Prevalence of cardiovascular diseases as well as cancer (12.1% vs. 7.0%, P  0.001) was higher in PAD patients with COPD compare…

Pulmonary and Respiratory MedicineAdultMalemedicine.medical_specialtyArterial diseasemedicine.medical_treatmentMyocardial InfarctionPulmonary diseaseDiseaseIndependent predictorAmputation Surgical03 medical and health sciencesPeripheral Arterial DiseasePulmonary Disease Chronic Obstructive0302 clinical medicineRisk FactorsInternal medicineNeoplasmsmedicinePrevalenceHumans030212 general & internal medicineHospital MortalityAgedAged 80 and overCOPDbusiness.industryNationwide databaseCancerMiddle Agedmedicine.diseaserespiratory tract diseases030228 respiratory systemAmputationCardiovascular DiseasesFemalebusinessPulmonary EmbolismRespiratory medicine
researchProduct

5-Year Experience of In-Hospital Outcomes After Percutaneous Left Atrial Appendage Closure in Germany

2019

The aim of this study was to evaluate 5-year in-hospital trends and safety outcomes of left atrial appendage (LAA) closure in the German nationwide inpatient sample.The safety and efficacy of percutaneous LAA closure have been demonstrated in randomized trials and prospective cohort studies, but results from large samples are missing.Data on patient characteristics and in-hospital safety outcomes for all percutaneous LAA closures performed in Germany between 2011 and 2015 were analyzed. Overall, 15,895 inpatients were included.The annual number of LAA occlusions increased from 1,347 in 2011 to 4,932 in 2015 (β = 1.00; 95% confidence interval [CI]: 0.95 to 1.01; p 0.001), with a nonsignifica…

MaleCardiac Catheterizationmedicine.medical_specialtyTime FactorsPercutaneousHealth StatusComorbidity030204 cardiovascular system & hematologyPericardial effusionlaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled trialRisk FactorslawCause of DeathGermanyAtrial FibrillationHumansMedicineAtrial AppendageHospital Mortality030212 general & internal medicineProspective cohort studyStrokeAgedAged 80 and overbusiness.industryMortality rateAtrial fibrillationmedicine.diseaseConfidence intervalSurgeryTreatment OutcomeAtrial Function LeftFemaleCardiology and Cardiovascular MedicinebusinessJACC: Cardiovascular Interventions
researchProduct

Management of Oral Anti-Coagulation in Patients with Heart Failure-Insights from the ThrombEVAL Study

2018

AbstractPatients with heart failure (HF) are frequently anti-coagulated with vitamin K-antagonists (VKAs). The use of long-acting VKA may be preferable for HF patients due to higher stability of plasma concentrations. However, evidence on phenprocoumon-based oral anti-coagulation (OAC) therapy in HF is scarce. The aim of this study was to assess the impact of the presence of HF on quality of phenprocoumon-based OAC and the subsequent clinical outcome. Quality of OAC therapy and the incidence of adverse events were analysed in a cohort of regular care (n = 2,011) from the multi-centre thrombEVAL study program (NCT01809015) stratified by the presence of HF. To assess the modifiability of outc…

MaleAdministration Oralheart failureclinical outcomeED AMERICAN-COLLEGE030204 cardiovascular system & hematologyTHERAPY ANTITHROMBOTIC THERAPYCohort StudiesPhenprocoumon0302 clinical medicinequality of careGermanyProspective Studies030212 general & internal medicineProspective cohort studyAged 80 and overOUTCOMESIncidenceHazard ratioHematologyTreatment OutcomeCohortFemaleCLINICAL-PRACTICE GUIDELINESSINUS RHYTHMmedicine.drugCohort studyRiskmedicine.medical_specialtyDrug-Related Side Effects and Adverse ReactionsHemorrhageWARFARINEJECTION FRACTION03 medical and health sciencesInternal medicinemedicineHumansAdverse effectAgedbusiness.industryWarfarinhealth care modelAnticoagulantsmedicine.diseaseoral anti-coagulationHeart failureATRIAL-FIBRILLATIONPhenprocoumonADVERSE EVENTSbusinessANTICOAGULANT-THERAPY
researchProduct

Evaluation of Risk Stratification Markers and Models in Acute Pulmonary Embolism: Rationale and Design of the MARS-PE (Mainz Retrospective Study of P…

2018

An acute pulmonary embolism (PE) is a crucial event in patients’ life and connected with serious morbidity and mortality. Regarding a high case-fatality rate, early and accurate risk-stratification is crucial. Risk for mortality and complications are closely related to hemodynamic stability and cardiac adaptations. The currently recommended risk-stratification approach is not overall simple to use and might delay the identification of those patients, who should be monitored more closely and may treated with more aggressive treatment strategies. Additionally, some risk-stratification criteria for the imaging procedures are still imprecise. Summarized, the search for the most effective risk-s…

AdultDiagnostic ImagingMalemedicine.medical_specialtypulmonary embolismlcsh:Medicinerisk stratification030204 cardiovascular system & hematologyRisk AssessmentSeverity of Illness Index03 medical and health sciences0302 clinical medicinestudy designRisk FactorsGermanyMedicineHumansIn patientIntensive care medicineAgedRetrospective Studiesbusiness.industrylcsh:RRetrospective cohort studyImaging ProceduresGeneral MedicineMiddle Agedmedicine.diseasePulmonary embolism030228 respiratory systemResearch DesignRisk stratificationAcute DiseaseoutcomeTreatment strategysymptomsFemaleHemodynamic stabilitybusinessBiomarkersActa Medica
researchProduct

In-hospital outcomes of catheter-directed thrombolysis in patients with pulmonary embolism

2020

Abstract Background and purpose Catheter-directed treatment of acute pulmonary embolism (PE) is technically advancing. Recent guidelines acknowledge this treatment option for patients with overt or imminent haemodynamic decompensation, particularly when systemic thrombolysis is contraindicated or has failed. We investigated baseline characteristics and in-hospital outcomes of patients with PE who underwent catheter-directed thrombolysis (CDT) in the German nationwide inpatient cohort. Methods Data from hospitalizations with PE between 2005 and 2016 were collected by the Federal Office of Statistics (Statistisches Bundesamt) in Germany and included in this analysis. Patients with PE who unde…

medicine.medical_specialtybusiness.industrymedicine.medical_treatmentMortality rateThrombolysisOdds ratiomedicine.diseaseLower riskPulmonary embolismInternal medicineCohortmedicineDecompensationCardiology and Cardiovascular MedicinebusinessFibrinolytic agentEuropean Heart Journal
researchProduct

Temporal Trends in the Prevalence of Infective Endocarditis in Germany Between 2005 and 2014

2016

Infective endocarditis (IE) is a potentially life-threatening disease. Little is known about temporal trends in its prevalence in Germany. In 2009, recommendations for antibiotic prophylaxis were deescalated in the revised European Society of Cardiology guideline to include only patients at high risk of IE. We selected patients with the discharge diagnosis of IE based on the International Classification of Diseases code I33 in the nationwide database of the Federal Statistical Office of Germany. We identified 94,364 patients with a diagnosis of IE from January 2005 to December 2014. Mean prevalence was 11.6 per 100,000 citizens per year in this 10-year-period. The annual IE prevalence showe…

Pediatricsmedicine.medical_specialtyEndocarditisbusiness.industryNationwide databaseGuidelineDisease030204 cardiovascular system & hematologymedicine.diseaseConfidence intervalHospitalization03 medical and health sciences0302 clinical medicineGermanyInfective endocarditisCase fatality ratePrevalenceHumansMedicineEndocarditis030212 general & internal medicineAntibiotic prophylaxisCardiology and Cardiovascular MedicinebusinessThe American Journal of Cardiology
researchProduct

Impact of pulmonary embolism on in-hospital mortality of patients with ischemic stroke

2020

Pulmonary embolism (PE) is a frequent complication in immobile stroke patients and an important cause of death in stroke patients. We aimed to investigate predictors of PE and the impact of PE on survival of ischemic stroke patients.Patients were selected by screening the German nationwide inpatient sample (2005-2017) for ischemic stroke (ICD-code I63) and stratified for occurrence of PE (ICD-code I26). Impact of PE on mortality and predictors for PE in ischemic stroke patients were analysed.Overall, 2,914,546 patients were hospitalized due to ischemic stroke (50.5% females; 69.3% aged ≥70 years) in Germany 2005-2017. Among these, 0.4% had PE and 7.2% died during hospitalization. In-hospita…

MaleResuscitationmedicine.medical_specialtymedicine.medical_treatmentBrain Ischemia03 medical and health sciences0302 clinical medicineGermanyInternal medicineHumansMedicineHospital Mortalitycardiovascular diseases030212 general & internal medicineAgedIschemic StrokeCause of deathIn hospital mortalitybusiness.industryMortality rateThrombolysismedicine.diseasePulmonary embolismStrokeNeurologyIschemic strokeCardiologyFemaleNeurology (clinical)Pulmonary EmbolismbusinessComplication030217 neurology & neurosurgeryJournal of the Neurological Sciences
researchProduct

D-Dimer and thrombus burden in acute pulmonary embolism.

2018

Abstract Background Thrombus burden in pulmonary embolism (PE) is associated with higher D-Dimer-levels and poorer prognosis. We aimed to investigate i) the influence of right ventricular dysfunction (RVD), deep venous thrombosis (DVT), and high-risk PE-status on D-Dimer-levels and ii) effectiveness of D-Dimer to predict RVD in normotensive PE patients. Methods Overall, 161 PE patients were analyzed retrospectively, classified in 5 subgroups of thrombus burden according to clinical indications and compared regarding D-Dimer-levels. Linear regression models were computed to investigate the association between D-Dimer and the groups. In hemodynamically stable PE patients, a ROC curve was calc…

Malemedicine.medical_specialtyVentricular Dysfunction Right030204 cardiovascular system & hematologyLogistic regressionFibrin Fibrinogen Degradation Products03 medical and health sciences0302 clinical medicineInternal medicineD-dimerLinear regressionmedicineHumans030212 general & internal medicineAgedRetrospective StudiesVenous Thrombosisbusiness.industryCancerGeneral Medicinemedicine.diseasePrognosisPulmonary embolismVenous thrombosisPneumoniaROC CurveThrombus burdenAcute DiseaseEmergency MedicineCardiologyFemalebusinessPulmonary EmbolismBiomarkersThe American journal of emergency medicine
researchProduct

Venous thromboembolism in patients hospitalized for knee and hip joint replacement surgery

2020

Abstract Background Venous thromboembolism (VTE) is a frequent acute cardiovascular disease, leading to significant morbidity and mortality worldwide. Major trauma, surgery, immobilisation and joint replacements are major provoking factors for VTE. In particular, patients undergoing knee and hip joint replacement surgery are at high risk of developing VTE perioperatively, even in the era of established pharmacological thromboprophylaxis. Without thromboprophylaxis, as many as 20–60% of patients may develop perioperative VTE. Purpose As recent studies indicate an increasing number of total knee and hip replacement surgeries in European countries and the United States, aims of our study were …

medicine.medical_specialtybusiness.industrymedicineIn patientCardiology and Cardiovascular MedicinebusinessVenous thromboembolismHip joint replacementSurgeryEuropean Heart Journal
researchProduct

Early symptomatic benefit indicates long-term prognosis after transcatheter mitral valve edge-to-edge repair in functional and degenerative etiology

2021

Mitral regurgitation (MR) is common in patients with heart failure and constitutes an independent risk factor for adverse prognosis besides NYHA-class. The predictive value of dyspnea reduction after transcatheter mitral valve repair (TMVr) on outcome has not been investigated up to now.We enrolled 627 consecutive patients (47.0% female, 57.4% functional MR; median follow-up 486 days[IQR 157/961]; survival status available in 96.8%; symptoms assessed in n = 556 at baseline / n = 406 at 1 month) treated with isolated percutaneous mitral valve edge-to-edge repair in our center from 06/2010-03/2018 (exclusion of combined forms of TMVr) in a monocentric retrospective analysis. Survival was 97.6…

Heart Valve Prosthesis ImplantationMaleMitral valve repairmedicine.medical_specialtyMitral regurgitationEjection fractionbusiness.industrymedicine.medical_treatmentMitraClipPrognosismedicine.diseaseSymptomatic reliefSurgeryTreatment Outcomemedicine.anatomical_structureInterquartile rangeHeart failureMitral valvemedicineHumansMitral ValveFemaleCardiology and Cardiovascular MedicinebusinessRetrospective StudiesInternational Journal of Cardiology
researchProduct

e-Health-based management of patients receiving oral anticoagulation therapy: results from the observational thrombEVAL study

2017

Essentials e-Health based health care by an expert centre may advance management of oral anticoagulation. Outcome of patients was compared between an e-health based coagulation service and regular care. Patients in the coagulation service cohort experienced a significantly better clinical outcome. Lower risk for adverse events was related to anticoagulation-specific and non-specific outcome. SummaryBackground Management of oral anticoagulation (OAC) therapy is essential to minimize adverse events in patients receiving vitamin K-antagonists (VKAs). Data on the effect of e-health-based anticoagulation management systems on the clinical outcome of OAC patients are limited. Objectives To compar…

MalePediatricsVitamin KAdministration OralComorbidity030204 cardiovascular system & hematologyRate ratioSERVICE0302 clinical medicineRisk FactorsGermanyUSUAL MEDICAL-CAREClinical endpointProspective Studies030212 general & internal medicineAged 80 and overOUTCOMESHazard ratioDABIGATRANHematologyMiddle AgedHospitalizationTreatment OutcomeCohortdelivery of healthcareFemaleepidemiologyPatient SafetytelemedicineCohort studymedicine.drugmedicine.medical_specialtyanticoagulantsHemorrhageLower riskpatient outcome assessmentWARFARIN03 medical and health sciencesThromboembolismmedicineNONVALVULAR ATRIAL-FIBRILLATIONHumansQUALITYInternational Normalized RatioAdverse effectBlood CoagulationMETAANALYSISAgedProportional Hazards ModelsRivaroxabanbusiness.industrySTROKE PREVENTIONRIVAROXABANbusinessFollow-Up Studies
researchProduct

Impact of diabetes mellitus on mortality rates and outcomes in myocardial infarction

2020

Diabetes mellitus (DM) represents a major cardiovascular risk factor for increased risk of coronary artery disease and myocardial infarction (MI). DM is also associated with a poorer clinical outcome in MI.The nationwide German inpatient population treated between 2005 and 2016 was used for statistical analyses. Hospitalized MI patients were stratified by the presence of DM and investigated for the impact of DM on in-hospital events.In total, 3,307,703 hospitalizations for acute MI (37.6% female patients, 56.8% aged ≥ 70 years) treated in Germany during 2005-2016 were included in this analysis. Of these patients, 410,737 (12.4%) died while in hospital. Overall, 1,007,326 (30.5%) MI cases we…

Malemedicine.medical_specialtyEndocrinology Diabetes and MetabolismPopulationMyocardial Infarction030209 endocrinology & metabolism030204 cardiovascular system & hematologyCoronary artery disease03 medical and health sciences0302 clinical medicineEndocrinologyDiabetes mellitusInternal medicineDiabetes MellitusInternal MedicinemedicineHumansHospital MortalityMyocardial infarctionRisk factoreducationAgededucation.field_of_studybusiness.industryMortality rateMetabolic disorderGeneral Medicinemedicine.diseaseTreatment OutcomeIncreased riskFemalebusinessDiabetes &amp; Metabolism
researchProduct

Impact of atrial fibrillation/flutter on the in-hospital mortality of surgical patients – Results from the German nationwide cohort

2020

To investigate the impact of atrial fibrillation/flutter (AF) on adverse in-hospital outcomes in hospitalized surgical patients.The nationwide German inpatient sample of the years 2005-2018 was used for this analysis. Surgical patients were stratified by AF and compared. Logistic regression models were used to investigate the impact of AF on in-hospital outcomes.In total, 96,589,627 hospitalizations with surgery were included in the present analysis in Germany (2005-2018). Among these, 6,680,261 were additionally coded with AF (6.9%). In-hospital death rate was substantially higher in surgical patients with AF (6.3%) than without (1.1%). Proportion of surgical patients with AF increased fro…

Malemedicine.medical_specialty030204 cardiovascular system & hematologyLogistic regression03 medical and health sciences0302 clinical medicineRisk FactorsGermanyInternal medicineAtrial FibrillationmedicineHumansHospital MortalityRisk factorHeart FailureAtrial fibrillation flutterIn hospital mortalitybusiness.industryMortality rateAtrial fibrillationHematologymedicine.diseaseAtrial Flutter030220 oncology & carcinogenesisCohortFemalebusinessSurgical patientsThrombosis Research
researchProduct

Predictors of short‐ and long‐term outcomes of patients undergoing transcatheter mitral valve edge‐to‐edge repair

2020

Objectives Transcatheter mitral valve repair (TMVR) by edge-to-edge therapy is an established treatment for severe mitral valve regurgitation (MR). Background Symptomatic and prognostic benefit in functional MR has been shown recently; nevertheless, data on long-term outcomes are sparse. Methods and results We analyzed survival of patients treated with isolated edge-to-edge repair from June 2010 to March 2018 (primarily combined edge-to-edge repair with other mitral valve interventions was excluded) in a retrospective monocentric study. Overall, 627 consecutive patients (47.0% females, 78.6 years in mean) were included. Leading etiology was functional MR (57.4%). Follow-up regarding surviva…

MaleCardiac Catheterizationmedicine.medical_specialtymedicine.medical_treatmentDischarged alive030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineMitral valveLong term outcomesmedicineHumansRadiology Nuclear Medicine and imaging030212 general & internal medicineRetrospective StudiesHeart Valve Prosthesis ImplantationCOPDMitral valve repairMitral regurgitationbusiness.industryMitral Valve InsufficiencyGeneral Medicinemedicine.diseaseSurgeryTreatment Outcomemedicine.anatomical_structureEtiologyMitral ValveFemaleCardiology and Cardiovascular MedicineMitral valve regurgitationbusinessCatheterization and Cardiovascular Interventions
researchProduct

Impact of cancer on the effectiveness of cardiac Troponin I to predict right ventricular dysfunction in acute pulmonary embolism

2015

Background Deep vein thrombosis (DVT) and pulmonary embolism (PE) are connected with a poor outcome in cancer patients. We aimed to investigate the impact of cancer on the effectiveness of cardiac Troponin I (cTnI) to predict right ventricular dysfunction (RVD) in acute PE. Methods We retrospectively analyzed the data of 182 patients with confirmed PE. PE patients were subdivided into two groups: (i) with concomitant active cancer disease or history of cancer, and (ii) without known cancer. Receiver operating characteristic (ROC) curves with area under the curve (AUC) was calculated for cTnI predicting RVD and related cut-off levels for both groups. Results Thirty-seven PE patients (20.3%) …

Pulmonary and Respiratory Medicinemedicine.medical_specialtyReceiver operating characteristicbusiness.industryDeep veinArea under the curveCancerGeneral Medicinemedicine.diseaseThrombosisSurgeryPulmonary embolismmedicine.anatomical_structureOncologyConcomitantInternal medicineTroponin Icardiovascular systemmedicineCardiologybusinessThoracic Cancer
researchProduct

PHQ-2 and GAD-2 scores predict mortality in patients undergoing oral anticoagulation

2015

Psychiatry and Mental healthClinical Psychologymedicine.medical_specialtybusiness.industryInternal medicinemedicineIn patientbusinessOral anticoagulationJournal of Psychosomatic Research
researchProduct

Temporal trends and predictors of inhospital death in patients hospitalised for heart failure in Germany.

2020

Abstract Aims We investigated trends in incidence, case fatality rate, patient characteristics and adverse inhospital events of patients hospitalised for heart failure in Germany. Methods and results The German nationwide inpatient sample (2005–2016) was used for this analysis. Patients hospitalised due to heart failure were selected for analysis. Temporal trends in the incidence of hospitalisations, case fatality rate and treatments were analysed and predictors of inhospital death were identified. The analysis comprised a total number of 4,539,140 hospitalisations (52.0% women, 81.0% aged ≥70 years) due to heart failure. Although hospitalisations increased from 381 (2005) to 539 per 100,00…

Heart transplantationHeart FailureMalemedicine.medical_specialtyEpidemiologybusiness.industryIncidence (epidemiology)medicine.medical_treatmentPatient characteristicsComorbiditymedicine.diseaseHospitalizationHeart failureGermanyCase fatality rateEmergency medicineMedicineHumansIn patientFemaleHospital MortalityCardiology and Cardiovascular MedicinebusinessAgedEuropean journal of preventive cardiology
researchProduct

Impact of Systemic Atherosclerosis on Clinical Characteristics and Short-Term Outcomes in Patients with Deep Venous Thrombosis or Thrombophlebitis

2020

Venous thromboembolism (VTE) and atherosclerosis are accompanied by substantial cardiovascular mortality; links between both disease entities were reported. We aimed to investigate the impact of systemic atherosclerosis on adverse outcomes in patients with deep venous thrombosis or thrombophlebitis (DVT) and to identify differences in DVT patients with and without systemic atherosclerosis.The German nationwide inpatient sample was used for this analysis. Patients admitted for DVT were included in this study and stratified by systemic atherosclerosis (composite of coronary artery disease, myocardial infarction, ischemic stroke, and/or atherosclerotic arterial diseases). We compared DVT patie…

Malemedicine.medical_specialtyDiseaseThrombophlebitisCoronary artery diseaseRisk FactorsInternal medicinemedicineHumanscardiovascular diseasesMyocardial infarctionVenous Thrombosisbusiness.industryVenous ThromboembolismGeneral MedicineThrombophlebitisAtherosclerosismedicine.diseasePulmonary embolismVenous thrombosisConcomitantHeart failureCardiologyFemalePulmonary EmbolismbusinessThe American Journal of the Medical Sciences
researchProduct

Hypertension is strongly associated with false-positive bicycle exercise stress echocardiography testing results

2016

Exercise echocardiography is a reliable routine test in patients with known or suspected coronary artery disease. However, in ∼15% of all patients, stress echocardiography leads to false-positive stress echocardiography results. We aimed to investigate the impact of hypertension on stress echocardiographic results.We performed a retrospective study of patients with suspected or known stable coronary artery disease who underwent a bicycle exercise stress echocardiography. Patients with false-positive stress results were compared with those with appropriate results.126 patients with suspected or known coronary artery disease were included in this retrospective study. 23 patients showed false-…

medicine.medical_specialtyCoronary Disease030204 cardiovascular system & hematologyCoronary artery disease03 medical and health sciences0302 clinical medicineInternal medicineInternal MedicinemedicineStress EchocardiographyHumansIn patient030212 general & internal medicineRetrospective Studiesbusiness.industryGender distributionRetrospective cohort studyGeneral Medicinemedicine.diseaseBicyclingBlood pressuremedicine.anatomical_structureEchocardiographyHypertensionExercise TestCardiologyExercise stress echocardiographyCardiology and Cardiovascular MedicinebusinessEchocardiography StressArteryBlood Pressure
researchProduct

Relevance of depression for anticoagulation management in a routine medical care setting: results from the ThrombEVAL study program

2014

Summary Background Depressive symptoms have detrimental effects on quality of life and mortality. Poor adherence to a treatment regimen is a potential mechanism for the increased risk of adverse medical events associated with depression. Regarding oral anticoagulation with vitamin K antagonists, adherence is crucial for the outcome. Little is known about the clinical relevance of current depressiveness for anticoagulation treatment. Objectives To examine the impact of current depressiveness on anticoagulation treatment in regular medical care. Patients/Methods We examined the association between clinically significant depressiveness as assessed by the Patient Health Questionnaire-2 ≥ 2 (PHQ…

Malemedicine.medical_specialtyCross-sectional studyAdministration OralHealth literacyMedication AdherenceCohort StudiesPatient satisfactionQuality of lifeAmbulatory careSurveys and QuestionnairesInternal medicineAmbulatory CarePrevalenceHumansMedicineClinical significanceInternational Normalized RatioDepression (differential diagnoses)AgedDepressionbusiness.industryAnticoagulantsHematologyMiddle AgedCross-Sectional StudiesTreatment OutcomePatient SatisfactionMultivariate AnalysisPhenprocoumonQuality of LifePhysical therapyFemalebusinessCohort studyJournal of Thrombosis and Haemostasis
researchProduct

Predictive value of the Kuijer score for bleeding and other adverse in-hospital events in patients with venous thromboembolism

2021

Venous thromboembolism (VTE) constitute a major global burden of disease. Current international guidelines recommend treatment with anticoagulant therapy after VTE for a duration of at least 3 months. Since anticoagulation also imposes an increased risk for bleeding events, the individual risk has to be evaluated to determine adequate treatment plans.The nationwide German inpatient sample of the years 2005-2017 was used for this analysis. Hospitalized VTE patients were stratified according to Kuijer risk class and the performance of the Kuijer score was evaluated to predict adverse in-hospital events.Overall, 1,204,895 VTE patients were treated between 2005 and 2017 in Germany and were incl…

medicine.medical_specialtyHemorrhage030204 cardiovascular system & hematologyThrombophlebitis03 medical and health sciences0302 clinical medicineRisk FactorsInterquartile rangeGermanyInternal medicinemedicineHumansIn patientHospital Mortality030212 general & internal medicinebusiness.industryAnticoagulantsVenous ThromboembolismOdds ratiomedicine.diseaseHospitalsConfidence intervalPulmonary embolismVenous thrombosisCardiology and Cardiovascular MedicinebusinessVenous thromboembolismInternational Journal of Cardiology
researchProduct

History of deep vein thrombosis is a discriminator for concomitant atrial fibrillation in pulmonary embolism.

2015

Pulmonary embolism (PE) is the consequence of deep vein thrombosis (DVT) in 70% of all cases. Although, PE and DVT are commonly related to risk factors of Virchow's triad, both entities are linked to cardiovascular risk factors, but risk factors seem differently important in both entities.We aimed to investigate clinical profile and outcome of patients with PE history stratified by concomitant DVT.Data from the observational multi-center thrombEVAL-study were analyzed.The sample (N=2,318) comprised 295 PE patients, of whom 69.2% (N=204) had DVT. Individuals without DVT were older and had higher prevalence of concomitant atrial fibrillation (AF), chronic lung diseases, coronary artery diseas…

Malemedicine.medical_specialtyDeep veinCoronary artery diseaseRisk FactorsInternal medicineAtrial FibrillationmedicineHumanscardiovascular diseasesAgedAged 80 and overVenous Thrombosisbusiness.industryAtrial fibrillationHematologyOdds ratiomedicine.diseaseThrombosisPulmonary embolismVenous thrombosismedicine.anatomical_structureHeart failureCardiologyFemalebusinessPulmonary EmbolismThrombosis research
researchProduct

Evaluation of oral anticoagulation therapy: Rationale and design of the thrombEVAL study programme

2013

Since decades, oral anticoagulation (OAC) with vitamin K antagonists (VKA) is an established therapy for both prevention and treatment of thromboembolism in daily clinical routine. Increasing life expectancy, demographic changes, and novel oral anticoagulants have led to an increasing complexity of medical therapy. However, data on quality and management of VKA therapy with phenprocoumon in current medical care are limited. Our aim is to investigate the quality of OAC with VKA in current health care and to evaluate the potential for improvements.The investigator-initiated thrombEVAL study programme comprises two cohorts of patients treated with vitamin K antagonists for oral anticoagulation…

medicine.medical_specialtyVitamin KEpidemiologymedicine.drug_classAdministration OralVitamin kPhenprocoumonThromboembolismmedicineHumansProspective StudiesQuality of careIntensive care medicineOral anticoagulationQuality of Health Carebusiness.industryAnticoagulantsVitamin K antagonistClinical routineTelemedicineResearch DesignIschemic strokePhenprocoumonCardiology and Cardiovascular Medicinebusinessmedicine.drugEuropean Journal of Preventive Cardiology
researchProduct

Relevance of Polypharmacy for Clinical Outcome in Patients Receiving Vitamin K Antagonists.

2018

BACKGROUND Although polypharmacy is associated with a negative clinical outcome in various settings and commonly observed in patients receiving oral anticoagulation therapy, evidence on the relevance for the clinical outcome of anticoagulated patients is currently limited. The aim of the study was to investigate the effect of polypharmacy on the clinical outcomes among patients taking phenprocoumon. DESIGN Prospective cohort study. SETTING Regular medical care. PARTICIPANTS Information on 2011 individuals receiving vitamin K antagonists was available for analysis from the prospective multicenter thrombEVAL study. MEASUREMENTS Data were obtained from clinical visits, computer-assisted interv…

Malemedicine.medical_specialtyVitamin KAdministration OralHemorrhage030204 cardiovascular system & hematologyPhenprocoumonCohort Studies03 medical and health sciences0302 clinical medicineRisk FactorsInternal medicineGermanyPrevalenceMedicineHumansCumulative incidenceDrug Interactions030212 general & internal medicineInternational Normalized RatioMultiple Chronic ConditionsProspective StudiesRisk factorMortalityProspective cohort studyAdverse effectAgedPolypharmacybusiness.industryMedical recordHazard ratioAnticoagulantsHospitalizationPolypharmacyFemaleGeriatrics and GerontologyDrug Monitoringbusinessmedicine.drugJournal of the American Geriatrics Society
researchProduct

Symptoms of depression and anxiety predict mortality in patients undergoing oral anticoagulation: Results from the thrombEVAL study program

2015

Abstract Background/objectives Depression and anxiety are highly prevalent in cardiovascular patients. Therefore, we examined whether the 4-item Patient Health Questionnaire (PHQ-4, measuring symptoms of depression and anxiety) predicts all-cause mortality in outpatients with long-term oral anticoagulation (OAC). Methods The sample comprised n=1384 outpatients from a regular medical care setting receiving long-term OAC with vitamin K antagonists. At baseline, symptoms of anxiety and depression were assessed with the PHQ-4 and the past medical history was taken. The outcome was all-cause mortality in the 24month observation period. The median follow-up time was 13.3months. Results N=191 pati…

Malemedicine.medical_specialtyVitamin KSickness Impact ProfileSurveys and QuestionnairesInternal medicinemedicineHumansMass ScreeningMedical historyProspective StudiesScreening proceduresDepression (differential diagnoses)AgedAged 80 and overDepressive DisorderPast medical historybusiness.industryMortality rateHazard ratioAnticoagulantsMiddle AgedAnxiety DisordersPatient Health QuestionnaireCardiovascular DiseasesPhysical therapyAnxietyFemalemedicine.symptomCardiology and Cardiovascular MedicinebusinessInternational Journal of Cardiology
researchProduct

Gitelman syndrome DD thiazide diuretics abuse

2014

Abstract Introduction. Gitelman syndrome (GS) is a rare inherited disorder. Mutations in SLC12A3 gene that encode tubular Na+Cl-cotransporter (NCCT) cause hypokalemic metabolic alkalosis, salt loss, hypomagnesaemia and hypocalciuria. The symptoms include weakness, vertigo, hypotension, tetany, paresthesia and nausea. Diagnostic criteria are a normal urine concentrating ability, normal glomerular filtration rate (GFR), hypomagnesaemia (&lt;0,65mmol/l), hypokalemia (&lt;3,6mmol/l) and hypocalciuria (&lt;0,1mmol/mmol creatinine). Previously, the diagnosis was made by exclusion. Today, genetic analysis can ensure diagnosis. Thiazide diuretics (TD) abuse with similar abnormalities can make the d…

slc12a3medicine.medical_specialtyTetanyhypomagnesaemiaRenal functionGastroenterologyHypocalciuriaPolyuriaInternal medicinehypokalemiamedicinehypocalciuriaThiazidenacl cotransporterbusiness.industrygitelmanRGeneral MedicineGitelman syndromemedicine.diseaseHypokalemiaEndocrinologyMedicinemedicine.symptombusinessMuscle crampmedicine.drugOpen Medicine
researchProduct

Concomitant history of cancer in acute pulmonary embolism is connected with poorer outcome

2015

Abstract Purpose: Cancer increases the risk of venous thromboembolism (VTE) substantially. VTE is connected with poorer outcome in cancer patients. The aim of our study was to investigate the impact of cancer on the severity and short-term outcome of pulmonary embolism (PE). Methods: We retrospectively analyzed the data of 182 patients with confirmed PE. PE patients were subdivided in the group with concomitant active cancer disease or history of cancer or in the group without cancer. Groups were compared with Wilcoxon–Mann–Whitney Test. Logistic regression models were calculated to investigate the association between cancer and several parameters such as age and PE severity status as well …

medicine.medical_specialtybusiness.industryCancerHematologyV q scanDiseasemedicine.diseaseLogistic regressionPulmonary embolismSurgeryOncologyInternal medicineConcomitantTroponin ImedicinebusinessVenous thromboembolismActa Haematologica Polonica
researchProduct

Sex-specific differences drive temporal trends and outcomes of patients hospitalized for heart failure in Germany

2020

Despite remarkable improvements in treatment of cardiovascular disease, heart failure (HF) is still characterized by high mortality rate. Sex-specific differences in HF have been described, but underlying reasons are widely unexplored.The nationwide German inpatient sample (2005-2016) was used for this sex-specific analyses. Temporal trends on hospitalizations, mortality, and treatments were analysed and independent predictors of adverse outcomes identified.The analysis comprises 4,538,977 hospitalizations due to HF (52.0%women) in Germany (2005-2016). Although women were older (median 82(IQR75-87) vs.76(69-82),P  0.001), coronary artery disease (CAD, 50.3% vs. 30.7%,P  0.001) was more prev…

Malemedicine.medical_specialtyTime FactorsDatabases FactualAdverse outcomesMEDLINEDisease030204 cardiovascular system & hematologyRisk Assessment03 medical and health sciencesSex Factors0302 clinical medicineGermanyInternal medicineCase fatality ratePrevalencemedicineHumansHospital Mortality030212 general & internal medicineHealthcare DisparitiesAgedAged 80 and overHeart Failurebusiness.industryIncidenceMortality rateIncidence (epidemiology)Health Status Disparitiesmedicine.diseaseSex specificHospitalizationOutcome and Process Assessment Health CareTreatment OutcomeHeart Disease Risk FactorsHeart failureFemaleCardiology and Cardiovascular MedicinebusinessProgress in Cardiovascular Diseases
researchProduct

Renal function as a cofactor for risk stratification and short-term outcome in acute pulmonary embolism

2017

Abstract Background In addition to right ventricular dysfunction (RVD) and myocardial injury, impaired renal function is connected with poorer prognosis in pulmonary embolism (PE). We aimed to investigate renal function as a cofactor for risk stratification in PE. Methods Data from 182 patients with PE, treated between May 2006 and June 2011, were analysed retrospectively. PE patients with elevated creatinine were compared with those with normal values. Logistic regression models were calculated to investigate associations between creatinine and myocardial necrosis, RVD and in-hospital death. Prognostic performance of creatinine for prediction of myocardial necrosis and RVD were computed. R…

MaleAgingmedicine.medical_specialtyVentricular Dysfunction RightRenal function030204 cardiovascular system & hematologyKidneyLogistic regressionRisk AssessmentBiochemistry03 medical and health scienceschemistry.chemical_compound0302 clinical medicineEndocrinologyGermanyInternal medicinemedicine.arteryTroponin IGeneticsmedicineHumans030212 general & internal medicineMolecular BiologyAgedRetrospective StudiesAged 80 and overKidneyCreatininebusiness.industryTroponin IRetrospective cohort studyCell BiologyMiddle AgedPrognosismedicine.diseasePulmonary embolismLogistic Modelsmedicine.anatomical_structureROC CurvechemistryEchocardiographyCreatinineAcute DiseaseMultivariate AnalysisPulmonary arteryCardiologyFemalePulmonary EmbolismbusinessExperimental Gerontology
researchProduct

Syncope and collapse in acute pulmonary embolism.

2016

Abstract Background Syncope and collapse (= presyncope) are 2 symptoms of pulmonary embolism (PE), which are suspected of being connected with poorer outcome, regardless of haemodynamic instability. However, pathomechanisms are not completely understood. We aimed to investigate these pathomechanisms in regard to blood pressure and heart rate of syncope/collapse in PE. Methods We performed a retrospective study of consecutive PE patients, who were treated in the Internal Medicine Department. Patients with and without syncope/collapse were compared. Regression models for associations between syncope/collapse and blood pressure, heart rate and shock index (SI) were computed. Moreover we calcul…

AdultMalemedicine.medical_specialtyCardiac outputDiastoleBlood Pressure030204 cardiovascular system & hematologySensitivity and SpecificitySyncope03 medical and health sciences0302 clinical medicineHeart RateInternal medicineHeart ratemedicineHumans030212 general & internal medicineCollapse (medical)AgedRetrospective StudiesAged 80 and overbiologybusiness.industrySyncope (genus)Retrospective cohort studyShockGeneral MedicineMiddle Agedbiology.organism_classificationmedicine.diseaseSurgeryPulmonary embolismBlood pressureAcute DiseaseEmergency MedicineCardiologyFemalemedicine.symptombusinessPulmonary EmbolismThe American journal of emergency medicine
researchProduct

Incidence of infective endocarditis before and after the guideline modification regarding a more restrictive use of prophylactic antibiotics therapy …

2019

Infective endocarditis (IE) is a potentially life-threatening disease. Regardless the improvements in IE management, it remains associated with high mortality and severe complications. Staphylococci and streptococci account for 80% of all IE cases. Prevention of IE by appropriate administration of antibiotics before procedures with potential bacteremia in selected patients is recommended according to recent and current guidelines. However, recent studies, have questioned the efficacy of antimicrobial prophylaxis in special situations and in some patient-groups. As a consequence, the guideline of the French working group on IE in 2002, the American Heart Association (AHA) guideline in 2007, …

medicine.medical_specialtyMEDLINENiceDisease030204 cardiovascular system & hematology03 medical and health sciencesPostoperative Complications0302 clinical medicinemedicineHumans030212 general & internal medicineAntibiotic prophylaxisIntensive care medicinecomputer.programming_languageEndocarditisbusiness.industryIncidenceIncidence (epidemiology)GuidelineAntibiotic Prophylaxismedicine.diseaseUnited StatesEuropeInfective endocarditisBacteremiaGuideline AdherenceCardiology and Cardiovascular MedicinebusinesscomputerMinerva Cardioangiologica
researchProduct

Elevated systolic pulmonary artery pressure for prediction of myocardial necrosis and right ventricular dysfunction in acute pulmonary embolism

2016

Kontext: Echokardiografie je v soucasnosti hlavni metodou pro vysetřeni dysfunkce prave komory (right ventricular dysfunction, RVD) u akutni plicni embolie (PE). Dysfunkce prave komory je sice spojena s nepřiznivou prognozou, dosud vsak nebyla přijata žadna obecně uznavana definice. Systolický tlak v plicnici (systolic pulmonary artery pressure, sPAP) větsinou neni soucasti kriterii RVD. Cilem nasi studie bylo zhodnotit možnost použiti sPAP v predikci nekrozy myokardu a RVD u akutni PE.Metody: Retrospektivně byly analyzovany udaje 182 pacientů s akutni PE. Pacienti s PE a hodnotami sPAP ≤ 30 mm Hg byli srovnavani s pacienty s PE a hodnotami sPAP > 30 mm Hg. Vztahy mezi sPAP na jedne straně …

medicine.medical_specialtyCardiac troponinmedicine.diagnostic_testbusiness.industryComputed tomographyV q scan030204 cardiovascular system & hematologymedicine.diseaseRight ventricular dysfunctionPulmonary embolism03 medical and health sciences0302 clinical medicineInternal medicinemedicine.arteryPulmonary arteryRisk stratificationmedicineCardiology030212 general & internal medicineMyocardial necrosisCardiology and Cardiovascular MedicinebusinessCor et Vasa
researchProduct

Cost-effectiveness of a Telemedicine-based Coagulation Service versus Routine Medical Care for the Management of Patients Receiving Vitamin K-antagon…

2019

Service (business)Telemedicinebusiness.industryCost effectivenessMedicineCoagulation (water treatment)Medical emergencyVitamin kbusinessmedicine.diseaseMedical careScience meets clinical practice
researchProduct

Risk Factors for Pulmonary Embolism in Patients with Paralysis and Deep Venous Thrombosis

2021

Background. Venous thromboembolism is a frequent complication and an important cause of death in patients with paralysis. We aimed to investigate predictors of pulmonary embolism (PE) and the impact of PE on the survival of patients with paralysis in comparison to those with deep venous thrombosis or thrombophlebitis (DVT). Methods: Patients were selected by screening the German nationwide inpatient sample (2005–2017) for paralysis, and were stratified for venous thromboembolism (VTE) and the VTE-sub-entity PE (ICD-code I26). Impact of PE on mortality and predictors for PE were analyzed. Results: Overall, 7,873,769 hospitalizations of patients with paralysis were recorded in Germany 2005–20…

medicine.medical_specialtyCOPDpulmonary embolismbusiness.industryRGeneral Medicineparalysismedicine.diseaseThrombophlebitisstrokemortalityArticlespinal cord injuryPulmonary embolismVenous thrombosisInternal medicineHeart failureParalysismedicineMedicinecardiovascular diseasesmedicine.symptombusinessStrokeCause of deathJournal of Clinical Medicine
researchProduct

Prognostic impact of copeptin in pulmonary embolism: a multicentre validation study.

2018

To externally validate the prognostic impact of copeptin, either alone or integrated in risk stratification models, in pulmonary embolism (PE), we performed a post hoc analysis of 843 normotensive PE patients prospectively included in three European cohorts.Within the first 30 days, 21 patients (2.5%, 95% CI 1.5–3.8) had an adverse outcome and 12 (1.4%, 95% CI 0.7–2.5) died due to PE. Patients with copeptin ≥24 pmol·L−1 had a 6.3-fold increased risk for an adverse outcome (95% CI 2.6–15.5, p&lt;0.001) and a 7.6-fold increased risk for PE-related death (95% CI 2.3–25.6, p=0.001). Risk classification according to the 2014 European Society of Cardiology (ESC) guideline algorithm identified 248…

Pulmonary and Respiratory MedicineMalemedicine.medical_specialtyValidation studyAdverse outcomes030204 cardiovascular system & hematologyRisk Assessment03 medical and health sciences0302 clinical medicineCopeptinRisk groupsRisk FactorsInternal medicinePost-hoc analysismedicineHumansProspective StudiesAgedAged 80 and overbusiness.industryGlycopeptidesMiddle Agedmedicine.diseasePrognosisPulmonary embolismIncreased riskLogistic Models030228 respiratory systemROC CurveRisk stratificationFemalebusinessPulmonary EmbolismAlgorithmsBiomarkersThe European respiratory journal
researchProduct

Quality of life and functional limitations after pulmonary embolism and its prognostic relevance

2019

Abstract Background While the importance of patients’ quality of life (QoL) in chronic cardiac or pulmonary disease is uncontroversial, the burden of an acute pulmonary embolism (PE) on QoL has received little attention thus far. Objectives We aimed to validate the German PEmb‐QoL questionnaire, identify associations between QoL and clinical/functional parameters, and investigate the prognostic relevance of QoL for long‐term survival in survivors of an acute PE episode. Patients/Methods Patients were invited for a clinical follow‐up visit including assessment of QoL using the German PEmb‐QoL questionnaire 6 months after an objectively confirmed PE at a single center. Internal consistency re…

Malemedicine.medical_specialtyTime FactorsPsychometricsPsychometricsHealth Status030204 cardiovascular system & hematologySingle Center03 medical and health sciences0302 clinical medicineCost of IllnessQuality of lifePredictive Value of TestsRisk FactorsInterquartile rangeGermanySurveys and QuestionnairesInternal medicinemedicineHumansProspective StudiesSurvivorsProspective cohort studyDepression (differential diagnoses)Agedbusiness.industryReproducibility of ResultsOriginal ArticlesHematologyMiddle AgedPrognosismedicine.diseasehumanities3. Good healthPulmonary embolismTHROMBOSISDyspneaPredictive value of testsQuality of LifeFemaleOriginal ArticleSymptom AssessmentPulmonary Embolismbusiness
researchProduct

Impact of concomitant deep or superficial venous thrombosis of the legs on survival of patients with pulmonary embolism

2019

Pulmonary embolism (PE) is a frequent cause of death and morbidity. A few studies suggest that clot burden in pulmonary artery bed is related to PE patients' survival, but the impact of concomitant deep venous thrombosis and/or thrombophlebitis (DVT) on short-term survival of PE patients remains unclear. Thus, we aimed to investigate the impact of DVT on adverse outcomes in PE patients.Patients of the nationwide inpatient sample with PE (ICD-code I26) were stratified for DVT (ICD-code I80) and compared for patient characteristics, risk stratification markers, treatments and outcomes. Impact of concomitant DVT on adverse in-hospital outcomes was tested.Overall, 346,586 PE patients (53.3% fem…

Malemedicine.medical_specialty030204 cardiovascular system & hematologyThrombophlebitis03 medical and health sciences0302 clinical medicineRisk FactorsInternal medicinemedicine.arterymedicineHumanscardiovascular diseases030212 general & internal medicineCause of deathVenous ThrombosisInpatientsLegbusiness.industryCancermedicine.diseasePulmonary embolismVenous thrombosisConcomitantPulmonary arterySuperficial venous thrombosisFemalePulmonary EmbolismCardiology and Cardiovascular MedicinebusinessInternational Journal of Cardiology
researchProduct

Strength and muscle mass loss with aging process. Age and strength loss.

2014

Background aging process is associated with changes in muscle mass and strength with decline of muscle strength after the 30(th) life year. The aim of this study was to investigate these changes in muscle mass and strength. Patients & methods for this analysis 26 participants were subdivided in two groups. Group 1 comprises participants aged 40 years (n=12). We assessed anthropometrics, range of motions, leg circumferences and isometric strength values of the knee joints. Results besides comparable anthropometrics, circumferences and strength were higher in group 1 than in group 2. Circumference of upper leg (20 cm above knee articular space) showed for right leg a trend to a significant (m…

medicine.medical_specialtybusiness.industry030229 sport sciencesIsometric exerciseStrength lossAnthropometrymedicine.diseaseCircumferenceMuscle mass03 medical and health sciencesArticular space0302 clinical medicineQuartileSarcopeniaInternal medicinemedicineCardiologyOrthopedics and Sports MedicineOriginal Articlebusiness030217 neurology & neurosurgeryMuscles, ligaments and tendons journal
researchProduct

Obesity paradox in peripheral artery disease

2019

Background & aims: Previous studies have suggested an obesity survival paradox in patients with peripheral artery disease (PAD). We investigated the influence of obesity and underweight on adverse in-hospital outcomes in PAD. Methods: Patients diagnosed with PAD based on ICD-code I70.2 of the German nationwide database were stratified for obesity, underweight and a reference group with normal-weight/over-weight and compared regarding adverse in-hospital outcomes. Results: Between 01/2005-12/2015, 5,611,484 inpatients (64.8% males) were diagnosed with PAD; of those, 8.9% were coded with obesity and 0.3% with underweight. Obese patients were younger (70 (IQR 63/76) vs. 73 (66/80) years, P < 0…

Male0301 basic medicinemedicine.medical_specialtyArterial diseasemedicine.medical_treatment030209 endocrinology & metabolismDiseaseCritical Care and Intensive Care MedicineCohort StudiesPeripheral Arterial Disease03 medical and health sciences0302 clinical medicineThinnessGermanyInternal medicineHumansMedicineHospital MortalityObesityAged030109 nutrition & dieteticsNutrition and Dieteticsbusiness.industryCancerMiddle Agedmedicine.diseaseObesityAmputationFemaleUnderweightmedicine.symptombusinessLower mortalityObesity paradoxClinical Nutrition
researchProduct

Impact of obesity on adverse in-hospital outcomes in patients undergoing percutaneous mitral valve edge-to-edge repair using MitraClip® procedure - R…

2019

Background and aim: The number of percutaneous edge-to-edge mitral regurgitation (MR) valve repairs with MitraClip® implantations increased exponentially in recent years. Studies have suggested an obesity survival paradox in patients with cardiovascular diseases. We investigated the influence of obesity on adverse in-hospital outcomes in patients with MitraClip® implantation. Methods and results: We analyzed data on characteristics of patients and in-hospital outcomes for all percutaneous mitral valve repairs using the edge-to-edge MitraClip®-technique in Germany 2011–2015 stratified for obesity vs. normal-weight/over-weight. The nationwide inpatient sample comprised 13,563 inpatients under…

MaleCardiac Catheterizationmedicine.medical_specialtyTime FactorsDatabases FactualEndocrinology Diabetes and Metabolismmedicine.medical_treatmentMedicine (miscellaneous)030209 endocrinology & metabolism030204 cardiovascular system & hematologyProsthesis DesignRisk Assessment03 medical and health sciencesPostoperative Complications0302 clinical medicineRisk FactorsGermanyInternal medicineMitral valvemedicineHumansHospital MortalityObesityAgedAged 80 and overHeart Valve Prosthesis ImplantationMechanical ventilationMitral regurgitationNutrition and Dieteticsbusiness.industryMitraClipMitral Valve Insufficiencymedicine.diseasePulmonary embolismTreatment Outcomemedicine.anatomical_structureHeart Valve ProsthesisHeart failureCardiologyFemaleCardiology and Cardiovascular MedicineMitral valve regurgitationbusinessObesity paradoxNutrition, Metabolism and Cardiovascular Diseases
researchProduct

Identification of normotensive patients with pulmonary embolism who may benefit from thrombolysis.

2019

medicine.medical_specialtybusiness.industrymedicine.medical_treatmentThrombolysismedicine.diseasePulmonary embolismFibrinolytic AgentsInternal medicinemedicineCardiologyHumansIdentification (biology)Thrombolytic TherapyCardiology and Cardiovascular MedicinebusinessPulmonary EmbolismInternational journal of cardiology
researchProduct

High-sensitivity troponin I for risk stratification in normotensive pulmonary embolism

2020

While numerous studies have confirmed the prognostic role of high-sensitivity troponin T (hsTnT) in pulmonary embolism (PE), high-sensitivity troponin I (hsTnI) is inappropriately studied. This study aimed to investigate the prognostic relevance of hsTnI in normotensive PE, establish the optimal cut-off value for risk stratification and to compare the prognostic performances of hsTnI and hsTnT. Based on data from 459 consecutive PE patients enrolled in a single-centre registry, receiver operating characteristic analysis was used to identify an optimal hsTnI cut-off value for prediction of in-hospital adverse outcomes (PE-related death, cardiopulmonary resuscitation or vasopressor treatment)…

Pulmonary and Respiratory Medicine7medicine.medical_specialtymedicine.medical_treatmentlcsh:Medicine030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineInternal medicineTroponin Imedicine030212 general & internal medicineCardiopulmonary resuscitationPulmonary Vascular DiseaseTroponin Tbusiness.industrylcsh:ROdds ratioOriginal Articlesmedicine.diseaseConfidence intervalPulmonary embolismHigh sensitivity troponinRisk stratificationCardiologybusinessERJ Open Research
researchProduct